3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Cardiotoxicity
14
Breast Neoplasms
10
Neoplasms
4
Heart Failure
4
Heart Diseases
2
Cardiovascular Diseases
2
Ventricular Dysfunction, Left
1
Ventricular Dysfunction
1
Thoracic Neoplasms
1
Radiation Injuries
1
Prostatic Neoplasms
1
Peritoneal Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Metabolic Syndrome
1
Memory Disorders
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Dyspnea
1
Dyslipidemias
1
Cognitive Dysfunction
1
Central Nervous System Neoplasms
1
Cardiomyopathies
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Bone Neoplasms
1
Atherosclerosis
1
Interventions
Blood Specimen Collection
3
Exercise
2
evolocumab
1
Ultrasonography, Carotid Arteries
1
Standard of Care
1
Rosuvastatin Calcium
1
Positron Emission Tomography Computed Tomography
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
Human Growth Hormone
1
Growth Hormone
1
Echocardiography
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Atherosclerosis
×
Echocardiography
×
Clear all
NCT06597045
2024-09-19
BIOCAPRI
NHS Greater Glasgow and Clyde
Active not recruiting
60 enrolled